Patricia H A Halkes

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. doi request reprint Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin
    P H A Halkes
    Department of Neurology, Rudolf Magnus Institute of Neuroscience and Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
    J Neurol Neurosurg Psychiatry 80:437-9. 2009
  2. ncbi request reprint Direct costs of surgical clipping and endovascular coiling of unruptured intracranial aneurysms
    Patricia H A Halkes
    Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Cerebrovasc Dis 22:40-5. 2006
  3. ncbi request reprint Large subcortical infarcts: clinical features, risk factors, and long-term prognosis compared with cortical and small deep infarcts
    Patricia H A Halkes
    Department of Neurology, Rudolf Magnus Institute, University Medical Center Utrecht, Utrecht, Netherlands
    Stroke 37:1828-32. 2006
  4. ncbi request reprint [Acetylsalicylic acid and dipyridamole offer better secondary protection than acetylsalicylic acid only following transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian Stroke Prevention in Reversible Ischaemia Tr
    P H A Halkes
    Ned Tijdschr Geneeskd 150:1832-8. 2006
  5. ncbi request reprint Classification of cause of death after stroke in clinical research
    Patricia H A Halkes
    Department of Neurology, Rudolf Magnus Institute, University Medical Center Utrecht, The Netherlands
    Stroke 37:1521-4. 2006
  6. doi request reprint Interpretation of ESPRIT in the FASTER trial
    Ale Algra
    Lancet Neurol 7:198-9; author reply 199. 2008

Detail Information

Publications6

  1. doi request reprint Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin
    P H A Halkes
    Department of Neurology, Rudolf Magnus Institute of Neuroscience and Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
    J Neurol Neurosurg Psychiatry 80:437-9. 2009
    ..63 (95% CI 0.58 to 0.68)) and in ESPS 2 with female sex and absence of ischaemic lesions on imaging (area under the ROC curve 0.64 (95% CI 0.59 to 0.69))...
  2. ncbi request reprint Direct costs of surgical clipping and endovascular coiling of unruptured intracranial aneurysms
    Patricia H A Halkes
    Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands
    Cerebrovasc Dis 22:40-5. 2006
    ..Unruptured intracranial aneurysms can be preventively treated by surgical clipping or endovascular coiling. We determined in detail the costs of these treatments...
  3. ncbi request reprint Large subcortical infarcts: clinical features, risk factors, and long-term prognosis compared with cortical and small deep infarcts
    Patricia H A Halkes
    Department of Neurology, Rudolf Magnus Institute, University Medical Center Utrecht, Utrecht, Netherlands
    Stroke 37:1828-32. 2006
    ..In this study we compared risk factors, clinical features, and stroke recurrence in a large series of patients with large subcortical, cortical, or small deep infarcts...
  4. ncbi request reprint [Acetylsalicylic acid and dipyridamole offer better secondary protection than acetylsalicylic acid only following transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian Stroke Prevention in Reversible Ischaemia Tr
    P H A Halkes
    Ned Tijdschr Geneeskd 150:1832-8. 2006
    ....
  5. ncbi request reprint Classification of cause of death after stroke in clinical research
    Patricia H A Halkes
    Department of Neurology, Rudolf Magnus Institute, University Medical Center Utrecht, The Netherlands
    Stroke 37:1521-4. 2006
    ..We aimed to develop guidelines for classifying such events...
  6. doi request reprint Interpretation of ESPRIT in the FASTER trial
    Ale Algra
    Lancet Neurol 7:198-9; author reply 199. 2008